KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 102 filers reported holding KALA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -98.7% | 15,977 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $383,000 | +23.5% | 56,828 | +24.1% | 0.00% | 0.0% |
| Q4 2020 | $310,000 | -51.5% | 45,776 | -46.3% | 0.00% | -77.8% |
| Q3 2020 | $639,000 | -67.8% | 85,255 | -54.8% | 0.01% | -71.9% |
| Q2 2020 | $1,984,000 | +4739.0% | 188,814 | +1593.1% | 0.03% | – |
| Q4 2019 | $41,000 | -48.8% | 11,152 | -11.2% | 0.00% | -100.0% |
| Q2 2019 | $80,000 | -41.2% | 12,553 | -55.0% | 0.00% | -50.0% |
| Q4 2018 | $136,000 | -44.5% | 27,871 | +12.4% | 0.00% | -33.3% |
| Q3 2018 | $245,000 | – | 24,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |